Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity	FUT3 FUT4 FUT7	5.13e-07	6	60	3	GO:0017083
GeneOntologyMolecularFunction	alpha-(1->3)-fucosyltransferase activity	FUT3 FUT4 FUT7	1.43e-06	8	60	3	GO:0046920
GeneOntologyMolecularFunction	fucosyltransferase activity	FUT3 FUT4 FUT7	9.17e-06	14	60	3	GO:0008417
GeneOntologyMolecularFunction	hexosyltransferase activity	B3GALT4 B4GALT7 FUT3 FUT4 FUT7	4.28e-04	211	60	5	GO:0016758
GeneOntologyMolecularFunction	voltage-gated chloride channel activity	CLCNKA CLCNKB	4.80e-04	11	60	2	GO:0005247
GeneOntologyBiologicalProcess	oligosaccharide metabolic process	B3GALT4 MAN2B2 FUT3 FUT4 FUT7	1.19e-06	70	55	5	GO:0009311
GeneOntologyBiologicalProcess	oligosaccharide biosynthetic process	B3GALT4 FUT3 FUT4 FUT7	1.35e-06	31	55	4	GO:0009312
GeneOntologyBiologicalProcess	fucosylation	FUT3 FUT4 FUT7	1.42e-05	18	55	3	GO:0036065
GeneOntologyBiologicalProcess	lymphocyte migration into lymph node	FUT4 FUT7	4.17e-05	4	55	2	GO:0097022
GeneOntologyBiologicalProcess	sphingolipid metabolic process	B3GALT4 NAGLU FUT3 FUT4 FUT7	1.05e-04	176	55	5	GO:0006665
GeneOntologyBiologicalProcess	angiogenesis involved in coronary vascular morphogenesis	ACE NRP1	1.45e-04	7	55	2	GO:0060978
GeneOntologyBiologicalProcess	vestibulocochlear nerve morphogenesis	DCANP1 NRP1	1.45e-04	7	55	2	GO:0021648
GeneOntologyBiologicalProcess	nerve development	DCANP1 NAGLU CHD7 NRP1	2.05e-04	109	55	4	GO:0021675
GeneOntologyBiologicalProcess	ceramide metabolic process	B3GALT4 NAGLU FUT3 FUT7	2.35e-04	113	55	4	GO:0006672
GeneOntologyBiologicalProcess	L-fucose catabolic process	FUT4 FUT7	2.48e-04	9	55	2	GO:0042355
GeneOntologyBiologicalProcess	fucose catabolic process	FUT4 FUT7	2.48e-04	9	55	2	GO:0019317
GeneOntologyBiologicalProcess	carbohydrate metabolic process	B3GALT4 B4GALT7 ADRB3 MAN2B2 PGGHG FUT3 FUT4 FUT7	2.94e-04	646	55	8	GO:0005975
GeneOntologyBiologicalProcess	lymphocyte migration into lymphoid organs	FUT4 FUT7	3.10e-04	10	55	2	GO:0097021
GeneOntologyBiologicalProcess	transepithelial chloride transport	CLCNKA CLCNKB	3.10e-04	10	55	2	GO:0030321
GeneOntologyBiologicalProcess	L-fucose metabolic process	FUT4 FUT7	3.10e-04	10	55	2	GO:0042354
GeneOntologyBiologicalProcess	membrane lipid metabolic process	B3GALT4 NAGLU FUT3 FUT4 FUT7	3.58e-04	229	55	5	GO:0006643
GeneOntologyBiologicalProcess	vestibulocochlear nerve development	DCANP1 NRP1	3.78e-04	11	55	2	GO:0021562
GeneOntologyBiologicalProcess	trigeminal nerve development	DCANP1 NRP1	5.34e-04	13	55	2	GO:0021559
GeneOntologyBiologicalProcess	macromolecule glycosylation	B3GALT4 B4GALT7 FUT3 FUT4 FUT7	5.53e-04	252	55	5	GO:0043413
GeneOntologyBiologicalProcess	protein glycosylation	B3GALT4 B4GALT7 FUT3 FUT4 FUT7	5.53e-04	252	55	5	GO:0006486
GeneOntologyBiologicalProcess	inner ear development	DCANP1 HLA-DMA NAGLU CHD7 MYO15A	5.63e-04	253	55	5	GO:0048839
GeneOntologyCellularComponent	Golgi cisterna membrane	B4GALT7 FUT3 FUT4 FUT7	1.10e-04	94	55	4	GO:0032580
GeneOntologyCellularComponent	Golgi cisterna	B4GALT7 FUT3 FUT4 FUT7	4.40e-04	135	55	4	GO:0031985
HumanPheno	Hypokalemic hypochloremic metabolic alkalosis	CLCNKA CLCNKB	2.42e-05	3	15	2	HP:0004909
HumanPheno	Hypochloremic metabolic alkalosis	CLCNKA CLCNKB	4.84e-05	4	15	2	HP:0005977
HumanPheno	Abnormal urine chloride concentration	CLCNKA CLCNKB	8.05e-05	5	15	2	HP:0012600
HumanPheno	Hyperchloriduria	CLCNKA CLCNKB	8.05e-05	5	15	2	HP:0002914
HumanPheno	Hyperprostaglandinuria	CLCNKA CLCNKB	1.21e-04	6	15	2	HP:0003527
HumanPheno	Abnormal circulating prostaglandin circulation	CLCNKA CLCNKB	1.21e-04	6	15	2	HP:0011023
HumanPheno	Hypochloremia	CLCNKA CLCNKB	1.69e-04	7	15	2	HP:0003113
HumanPheno	Impaired renal concentrating ability	CLCNKA CLCNKB	1.69e-04	7	15	2	HP:0004727
HumanPheno	Hyperactive renin-angiotensin system	CLCNKA CLCNKB	2.24e-04	8	15	2	HP:0000841
HumanPheno	Abnormal circulating unsaturated fatty acid concentration	CLCNKA CLCNKB	2.24e-04	8	15	2	HP:0011022
HumanPheno	Abnormal circulating eicosanoid concentration	CLCNKA CLCNKB	2.24e-04	8	15	2	HP:0030361
HumanPheno	Impaired renal function	CLCNKA CLCNKB	2.88e-04	9	15	2	HP:0000087
HumanPheno	Hypokalemic metabolic alkalosis	CLCNKA CLCNKB	2.88e-04	9	15	2	HP:0001960
HumanPheno	Increased urinary potassium	CLCNKA CLCNKB	2.88e-04	9	15	2	HP:0003081
HumanPheno	Hypernatriuria	CLCNKA CLCNKB	3.59e-04	10	15	2	HP:0012605
HumanPheno	Hypokalemic alkalosis	CLCNKA CLCNKB	5.25e-04	12	15	2	HP:0001949
HumanPheno	Fetal polyuria	CLCNKA CLCNKB	5.25e-04	12	15	2	HP:0001563
Domain	Glyco_transf_10	FUT3 FUT4 FUT7	1.34e-06	8	55	3	PF00852
Domain	Glyco_tran_10_N	FUT3 FUT4 FUT7	1.34e-06	8	55	3	PF17039
Domain	Glyco_trans_10	FUT3 FUT4 FUT7	1.34e-06	8	55	3	IPR001503
Domain	Glyco_tran_10_N	FUT3 FUT4 FUT7	1.34e-06	8	55	3	IPR031481
Domain	Cl_channel-K	CLCNKA CLCNKB	8.51e-06	2	55	2	IPR002250
Domain	ig	CEACAM5 TIE1 HLA-DMA ADAMTSL3 LILRA4	2.38e-04	190	55	5	PF00047
Domain	Immunoglobulin	CEACAM5 TIE1 HLA-DMA ADAMTSL3 LILRA4	2.38e-04	190	55	5	IPR013151
Domain	Cl-channel_core	CLCNKA CLCNKB	3.02e-04	9	55	2	IPR014743
Domain	-	CLCNKA CLCNKB	3.02e-04	9	55	2	1.10.3080.10
Domain	Voltage_CLC	CLCNKA CLCNKB	3.02e-04	9	55	2	PF00654
Domain	Cl-channel_volt-gated	CLCNKA CLCNKB	3.02e-04	9	55	2	IPR001807
Domain	Ig-like_dom	CEACAM5 CSF3R TIE1 HLA-DMA ROBO3 ADAMTSL3 LILRA4	6.54e-04	503	55	7	IPR007110
Domain	UBA-like	ILRUN UBALD2 TNRC6C	8.87e-04	64	55	3	IPR009060
Domain	CBS	CLCNKA CLCNKB	9.95e-04	16	55	2	SM00116
Domain	CBS_dom	CLCNKA CLCNKB	1.56e-03	20	55	2	IPR000644
Domain	CBS	CLCNKA CLCNKB	1.56e-03	20	55	2	PF00571
Domain	CBS	CLCNKA CLCNKB	1.56e-03	20	55	2	PS51371
Domain	Ig-like_fold	CEACAM5 CSF3R TIE1 HLA-DMA ROBO3 ADAMTSL3 LILRA4	4.49e-03	706	55	7	IPR013783
Domain	IGc2	CEACAM5 ROBO3 ADAMTSL3 LILRA4	5.04e-03	235	55	4	SM00408
Domain	Ig_sub2	CEACAM5 ROBO3 ADAMTSL3 LILRA4	5.04e-03	235	55	4	IPR003598
Pathway	REACTOME_BLOOD_GROUP_SYSTEMS_BIOSYNTHESIS	B3GALT4 FUT3 FUT4 FUT7	2.33e-07	21	37	4	M27917
Pathway	KEGG_MEDICUS_REFERENCE_SIALYL_LEWIS_X_ANTIGEN_BIOSYNTHESIS	FUT3 FUT4 FUT7	3.31e-07	6	37	3	M47967
Pathway	REACTOME_METABOLISM_OF_CARBOHYDRATES	B3GALT4 B4GALT7 MAN2B2 NAGLU FUT3 FUT4 FUT7	8.41e-06	288	37	7	M16864
Pathway	REACTOME_BLOOD_GROUP_SYSTEMS_BIOSYNTHESIS	B3GALT4 FUT4 FUT7	1.10e-05	17	37	3	MM15629
Pathway	KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES	FUT3 FUT4 FUT7	4.15e-05	26	37	3	M17377
Pathway	KEGG_MEDICUS_REFERENCE_LEWIS_X_ANTIGEN_BIOSYNTHESIS	FUT3 FUT4	6.67e-05	5	37	2	M47966
Pathway	REACTOME_METABOLISM_OF_CARBOHYDRATES	B3GALT4 B4GALT7 MAN2B2 NAGLU FUT4 FUT7	6.73e-05	271	37	6	MM15406
Pathway	BIOCARTA_AMAN_PATHWAY	FUT4 FUT7	2.39e-04	9	37	2	MM1535
Pathway	BIOCARTA_AMAN_PATHWAY	FUT4 FUT7	6.89e-04	15	37	2	M22009
Pubmed	Composition of Drosophila melanogaster proteome involved in fucosylated glycan metabolism.	FUT3 FUT4 FUT7	2.54e-06	15	63	3	11698403
Pubmed	Lack of functional selectin ligand interactions compromises long term tumor protection by CD8+ T cells.	FUT4 FUT7	3.23e-06	2	63	2	22359671
Pubmed	Cloning, tissue distribution, and intrarenal localization of ClC chloride channels in human kidney.	CLCNKA CLCNKB	3.23e-06	2	63	2	8544406
Pubmed	α(1,3)-Fucosyltransferases FUT4 and FUT7 control murine susceptibility to thrombosis.	FUT4 FUT7	3.23e-06	2	63	2	23562273
Pubmed	The ClC-K2 Chloride Channel Is Critical for Salt Handling in the Distal Nephron.	CLCNKA CLCNKB	3.23e-06	2	63	2	27335120
Pubmed	Lack of functional selectin-ligand interactions enhances innate immune resistance to systemic Listeria monocytogenes infection.	FUT4 FUT7	3.23e-06	2	63	2	29345354
Pubmed	Assignment of the genes encoding the human chloride channels, CLCNKA and CLCNKB, to 1p36 and of CLCN3 to 4q32-q33 by in situ hybridization.	CLCNKA CLCNKB	3.23e-06	2	63	2	8812470
Pubmed	The alpha(1,3)fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis.	FUT4 FUT7	3.23e-06	2	63	2	8752218
Pubmed	Associations between CLCNKA_B tag SNPs with essential hypertension and interactions between genetic and environmental factors in an island population in China.	CLCNKA CLCNKB	3.23e-06	2	63	2	25919862
Pubmed	Targeting kidney CLC-K channels: pharmacological profile in a human cell line versus Xenopus oocytes.	CLCNKA CLCNKB	3.23e-06	2	63	2	24863058
Pubmed	Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel.	CLCNKA CLCNKB	3.23e-06	2	63	2	9916798
Pubmed	Kidney kinetics and chloride ion pumps.	CLCNKA CLCNKB	3.23e-06	2	63	2	9916791
Pubmed	Fucosyltransferase 4 and 7 mediates adhesion of non-small cell lung cancer cells to brain-derived endothelial cells and results in modification of the blood-brain-barrier: in vitro investigation of CD15 and CD15s in lung-to-brain metastasis.	FUT4 FUT7	3.23e-06	2	63	2	31104223
Pubmed	The alpha(1,3)fucosyltransferases FucT-IV and FucT-VII exert collaborative control over selectin-dependent leukocyte recruitment and lymphocyte homing.	FUT4 FUT7	3.23e-06	2	63	2	11485743
Pubmed	Abrogation of functional selectin-ligand expression reduces migration of pathogenic CD8+ T cells into heart.	FUT4 FUT7	3.23e-06	2	63	2	16709814
Pubmed	Memory T cells are enriched in lymph nodes of selectin-ligand-deficient mice.	FUT4 FUT7	3.23e-06	2	63	2	20937846
Pubmed	Expanding Genotype-Phenotype Correlation of CLCNKA and CLCNKB Variants Linked to Hearing Loss.	CLCNKA CLCNKB	3.23e-06	2	63	2	38069401
Pubmed	Selectin ligand-independent priming and maintenance of T cell immunity during airborne tuberculosis.	FUT4 FUT7	3.23e-06	2	63	2	16394002
Pubmed	A regulatory calcium-binding site at the subunit interface of CLC-K kidney chloride channels.	CLCNKA CLCNKB	3.23e-06	2	63	2	20805576
Pubmed	Synthesis of {alpha}(1,3) fucosyltransferases IV- and VII-dependent eosinophil selectin ligand and recruitment to the skin.	FUT4 FUT7	3.23e-06	2	63	2	16127157
Pubmed	Regulation of PSGL-1 interactions with L-selectin, P-selectin, and E-selectin: role of human fucosyltransferase-IV and -VII.	FUT4 FUT7	3.23e-06	2	63	2	15579466
Pubmed	Fuc-TVII is required for T helper 1 and T cytotoxic 1 lymphocyte selectin ligand expression and recruitment in inflammation, and together with Fuc-TIV regulates naive T cell trafficking to lymph nodes.	FUT4 FUT7	3.23e-06	2	63	2	11535629
Pubmed	[Influence of angiotensin converting enzyme gene insertion/deletion polymorphism and beta3-adrenergic receptor gene Trp64Arg polymorphism on fetal growth and neonatal insulin sensitivity].	ADRB3 ACE	3.23e-06	2	63	2	19099777
Pubmed	Fucosyltransferase Induction during Influenza Virus Infection Is Required for the Generation of Functional Memory CD4+ T Cells.	FUT4 FUT7	3.23e-06	2	63	2	29491007
Pubmed	Fucosyltransferase IV and VII-directed selectin ligand function determines long-term survival in experimental tuberculosis.	FUT4 FUT7	3.23e-06	2	63	2	19608009
Pubmed	Salt wasting and deafness resulting from mutations in two chloride channels.	CLCNKA CLCNKB	3.23e-06	2	63	2	15044642
Pubmed	Pathophysiological contributions of fucosyltransferases in renal ischemia reperfusion injury.	FUT4 FUT7	3.23e-06	2	63	2	12193737
Pubmed	Two highly homologous members of the ClC chloride channel family in both rat and human kidney.	CLCNKA CLCNKB	3.23e-06	2	63	2	8041726
Pubmed	A cytoplasmic domain mutation in ClC-Kb affects long-distance communication across the membrane.	CLCNKA CLCNKB	3.23e-06	2	63	2	18648499
Pubmed	Cl(-) channels in basolateral TAL membranes XV. Molecular heterogeneity between cortical and medullary channels.	CLCNKA CLCNKB	3.23e-06	2	63	2	11014860
Pubmed	Silencing α1,3-fucosyltransferases in human leukocytes reveals a role for FUT9 enzyme during E-selectin-mediated cell adhesion.	FUT4 FUT7	9.68e-06	3	63	2	23192350
Pubmed	Murine neutrophils require alpha1,3-fucosylation but not PSGL-1 for productive infection with Anaplasma phagocytophilum.	FUT4 FUT7	9.68e-06	3	63	2	12869507
Pubmed	Human CLC-K Channels Require Palmitoylation of Their Accessory Subunit Barttin to Be Functional.	CLCNKA CLCNKB	9.68e-06	3	63	2	26013830
Pubmed	Barttin increases surface expression and changes current properties of ClC-K channels.	CLCNKA CLCNKB	9.68e-06	3	63	2	12111250
Pubmed	Common genetic variants and haplotypes in renal CLCNKA gene are associated to salt-sensitive hypertension.	CLCNKA CLCNKB	9.68e-06	3	63	2	17510212
Pubmed	A role for leukocyte-endothelial adhesion mechanisms in epilepsy.	FUT4 FUT7	9.68e-06	3	63	2	19029985
Pubmed	Efficient recruitment of lymphocytes in inflamed brain venules requires expression of cutaneous lymphocyte antigen and fucosyltransferase-VII.	FUT4 FUT7	9.68e-06	3	63	2	15843584
Pubmed	Naïve T cells re-distribute to the lungs of selectin ligand deficient mice.	FUT4 FUT7	9.68e-06	3	63	2	20532047
Pubmed	Suppression of tumor formation in lymph nodes by L-selectin-mediated natural killer cell recruitment.	FUT4 FUT7	9.68e-06	3	63	2	16352740
Pubmed	Difucosylated oligosaccharide Lewis Y is contained within integrin αvβ3 on RL95-2 cells and required for endometrial receptivity.	FUT3 FUT4	9.68e-06	3	63	2	20605574
Pubmed	T-cell P/E-selectin ligand alpha(1,3)fucosylation is not required for graft-vs-host disease induction.	FUT4 FUT7	9.68e-06	3	63	2	16338500
Pubmed	Binding of L-selectin to its vascular and extravascular ligands is differentially regulated by pH.	FUT4 FUT7	9.68e-06	3	63	2	21982762
Pubmed	Alpha(1,3)fucosyltransferases FucT-IV and FucT-VII control susceptibility to atherosclerosis in apolipoprotein E-/- mice.	FUT4 FUT7	9.68e-06	3	63	2	15308551
Pubmed	Isolation of a novel human alpha (1,3)fucosyltransferase gene and molecular comparison to the human Lewis blood group alpha (1,3/1,4)fucosyltransferase gene. Syntenic, homologous, nonallelic genes encoding enzymes with distinct acceptor substrate specificities.	FUT3 FUT4	9.68e-06	3	63	2	1740457
Pubmed	Barttin is a Cl- channel beta-subunit crucial for renal Cl- reabsorption and inner ear K+ secretion.	CLCNKA CLCNKB	9.68e-06	3	63	2	11734858
Pubmed	Metastatic growth progression caused by PSGL-1-mediated recruitment of monocytes to metastatic sites.	FUT4 FUT7	9.68e-06	3	63	2	24322980
Pubmed	CD15 expression in mature granulocytes is determined by alpha 1,3-fucosyltransferase IX, but in promyelocytes and monocytes by alpha 1,3-fucosyltransferase IV.	FUT4 FUT7	9.68e-06	3	63	2	11278338
Pubmed	Barttin modulates trafficking and function of ClC-K channels.	CLCNKA CLCNKB	9.68e-06	3	63	2	16849430
Pubmed	Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance.	FUT4 FUT7	9.68e-06	3	63	2	32341362
Pubmed	α(1,3) Fucosyltransferases IV and VII are essential for the initial recruitment of basophils in chronic allergic inflammation.	FUT4 FUT7	9.68e-06	3	63	2	23657464
Pubmed	Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity.	FUT4 FUT7	9.68e-06	3	63	2	22388819
Pubmed	Mechanisms of Disease: the kidney-specific chloride channels ClCKA and ClCKB, the Barttin subunit, and their clinical relevance.	CLCNKA CLCNKB	9.68e-06	3	63	2	18094726
Pubmed	Transcriptional regulation of the CLC-K1 promoter by myc-associated zinc finger protein and kidney-enriched Krüppel-like factor, a novel zinc finger repressor.	CLCNKA CLCNKB	9.68e-06	3	63	2	10982849
Pubmed	Haplotype diversity in four genes (CLCNKA, CLCNKB, BSND, NEDD4L) involved in renal salt reabsorption.	CLCNKA CLCNKB	1.93e-05	4	63	2	17652939
Pubmed	Monocyte Induction of E-Selectin-Mediated Endothelial Activation Releases VE-Cadherin Junctions to Promote Tumor Cell Extravasation in the Metastasis Cascade.	FUT4 FUT7	1.93e-05	4	63	2	27488527
Pubmed	The Lewis X-related α1,3-fucosyltransferase, Fut10, is required for the maintenance of stem cell populations.	FUT4 FUT7	1.93e-05	4	63	2	23986452
Pubmed	Arteriogenesis proceeds via ICAM-1/Mac-1- mediated mechanisms.	FUT4 FUT7	1.93e-05	4	63	2	15059933
Pubmed	Cellular players and role of selectin ligands in leukocyte recruitment in a T-cell-initiated delayed-type hypersensitivity reaction.	FUT4 FUT7	1.93e-05	4	63	2	18755847
Pubmed	A novel monoclonal antibody against 6-sulfo sialyl Lewis x glycans attenuates murine allergic rhinitis by suppressing Th2 immune responses.	FUT4 FUT7	1.93e-05	4	63	2	37735247
Pubmed	Heparin-induced leukocytosis requires 6-O-sulfation and is caused by blockade of selectin- and CXCL12 protein-mediated leukocyte trafficking in mice.	FUT4 FUT7	1.93e-05	4	63	2	22194593
Pubmed	Specialized contributions by alpha(1,3)-fucosyltransferase-IV and FucT-VII during leukocyte rolling in dermal microvessels.	FUT4 FUT7	1.93e-05	4	63	2	10894166
Pubmed	Notch-dependent control of myelopoiesis is regulated by fucosylation.	FUT4 FUT7	1.93e-05	4	63	2	18359890
Pubmed	Expression of functional P-selectin glycoprotein ligand 1 on hematopoietic progenitors is developmentally regulated.	FUT4 FUT7	1.93e-05	4	63	2	22461691
Pubmed	Skin-homing receptors on effector leukocytes are differentially sensitive to glyco-metabolic antagonism in allergic contact dermatitis.	FUT4 FUT7	1.93e-05	4	63	2	18056398
Pubmed	The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics.	FUT4 FUT7	3.22e-05	5	63	2	18037890
Pubmed	N-acetylglucosamine-6-O-sulfotransferases 1 and 2 cooperatively control lymphocyte homing through L-selectin ligand biosynthesis in high endothelial venules.	FUT4 FUT7	3.22e-05	5	63	2	16227985
Pubmed	Distinct human α(1,3)-fucosyltransferases drive Lewis-X/sialyl Lewis-X assembly in human cells.	FUT3 FUT4	3.22e-05	5	63	2	29593094
Pubmed	[Correlation of metabolic syndrome clinical signs and genetic determinants at children with obese].	ADRB3 ACE	4.82e-05	6	63	2	21033077
Pubmed	Novel anti-carbohydrate antibodies reveal the cooperative function of sulfated N- and O-glycans in lymphocyte homing.	FUT4 FUT7	4.82e-05	6	63	2	20929857
Pubmed	Embryonic trafficking of gammadelta T cells to skin is dependent on E/P selectin ligands and CCR4.	FUT4 FUT7	4.82e-05	6	63	2	20368416
Pubmed	L-selectin mechanochemistry restricts neutrophil priming in vivo.	FUT4 FUT7	4.82e-05	6	63	2	28497779
Pubmed	Functional contributions of N- and O-glycans to L-selectin ligands in murine and human lymphoid organs.	FUT4 FUT7	4.82e-05	6	63	2	21224079
Pubmed	Genetic association of angiogenesis- and hypoxia-related gene polymorphisms with osteonecrosis of the femoral head.	ACE NRP1	4.82e-05	6	63	2	20215856
Pubmed	Physiological contribution of CD44 as a ligand for E-Selectin during inflammatory T-cell recruitment.	FUT4 FUT7	4.82e-05	6	63	2	21457936
Pubmed	Sialyltransferase ST3Gal-III regulates Siglec-F ligand formation and eosinophilic lung inflammation in mice.	FUT4 FUT7	6.74e-05	7	63	2	23677475
Pubmed	Impairment in renal medulla development underlies salt wasting in Clc-k2 channel deficiency.	CLCNKA CLCNKB	6.74e-05	7	63	2	34499620
Pubmed	DC-SIGN(+) Macrophages Control the Induction of Transplantation Tolerance.	FUT4 FUT7	6.74e-05	7	63	2	26070485
Pubmed	Intrarenal and cellular localization of CLC-K2 protein in the mouse kidney.	CLCNKA CLCNKB	6.74e-05	7	63	2	11423561
Pubmed	Mouse embryonic dorsal root ganglia contain pluripotent stem cells that show features similar to embryonic stem cells and induced pluripotent stem cells.	CHD7 FUT4	8.98e-05	8	63	2	28373172
Pubmed	VEGF mediates commissural axon chemoattraction through its receptor Flk1.	ROBO3 NRP1	8.98e-05	8	63	2	21658588
Pubmed	Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17.	FUT4 FUT7	1.15e-04	9	63	2	15780986
Pubmed	Changing expression of chloride channels during preimplantation mouse development.	CLCNKA CLCNKB	1.15e-04	9	63	2	23115349
Pubmed	Sex differences in environmental and genetic factors for hypertension.	ADRB3 ACE	1.44e-04	10	63	2	18724972
Pubmed	Genetic and environmental factors associated with the development of hypertension in pregnancy.	ADRB3 ACE	1.76e-04	11	63	2	16369102
Pubmed	Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response.	FUT4 FUT7	1.76e-04	11	63	2	19303390
Pubmed	Genetic factors are relevant and independent determinants of antihypertensive drug effects in a multiracial population.	ADRB3 ACE	1.76e-04	11	63	2	19779464
Pubmed	The basic helix-loop-helix transcription factor, dHAND, is required for vascular development.	TIE1 NRP1	2.49e-04	13	63	2	10675351
Pubmed	Neuropilin 1 sequestration by neuropathogenic mutant glycyl-tRNA synthetase is permissive to vascular homeostasis.	TIE1 NRP1	2.49e-04	13	63	2	28835631
Pubmed	CEACAM1 regulates insulin clearance in liver.	CEACAM5 MAP3K10	2.90e-04	14	63	2	11850617
Pubmed	Carcinoembryonic antigen-related cell adhesion molecule-1 regulates granulopoiesis by inhibition of granulocyte colony-stimulating factor receptor.	CEACAM5 CSF3R	3.34e-04	15	63	2	21029969
Pubmed	Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability.	ROBO3 NRP1	3.34e-04	15	63	2	18345009
Pubmed	Identification and characterization of large galactosyltransferase gene families: galactosyltransferases for all functions.	B3GALT4 B4GALT7	3.81e-04	16	63	2	10580128
Pubmed	The thiazide-sensitive Na(+)-Cl(-) cotransporter gene, C1784T, and adrenergic receptor-beta3 gene, T727C, may be gene polymorphisms susceptible to the antihypertensive effect of thiazide diuretics.	ADRB3 ACE	3.81e-04	16	63	2	15824464
Pubmed	Optic chiasm presentation of Semaphorin6D in the context of Plexin-A1 and Nr-CAM promotes retinal axon midline crossing.	FUT4 NRP1	3.81e-04	16	63	2	22632726
Pubmed	Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis.	ADRB3 ACE	3.81e-04	16	63	2	10391210
Pubmed	TRIM24 is an insulin-responsive regulator of P-bodies.	TNRC6C EDC4 GARRE1	4.21e-04	80	63	3	35803934
Pubmed	Comprehensive analysis of low-abundance proteins in human urinary exosomes using peptide ligand library technology, peptide OFFGEL fractionation and nanoHPLC-chip-MS/MS.	NAGLU ACE	4.32e-04	17	63	2	21082674
Pubmed	VEGF signaling through neuropilin 1 guides commissural axon crossing at the optic chiasm.	FUT4 NRP1	6.01e-04	20	63	2	21658587
Pubmed	Can we predict top-level sports performance in power vs endurance events? A genetic approach.	ADRB3 ACE	6.01e-04	20	63	2	20459474
Pubmed	Endothelial PlexinD1 signaling instructs spinal cord vascularization and motor neuron development.	SLC10A4 NRP1	7.29e-04	22	63	2	36549270
GeneFamily	Fucosyltransferases\|Blood group antigens	FUT3 FUT4 FUT7	2.61e-06	13	39	3	434
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	CEACAM5 CSF3R FUT3 FUT4 ACE LILRA4 NRP1	1.86e-05	394	39	7	471
GeneFamily	Chloride voltage-gated channels	CLCNKA CLCNKB	2.02e-04	10	39	2	302
GeneFamily	Immunoglobulin like domain containing	CEACAM5 TIE1 ROBO3 ADAMTSL3	7.73e-04	193	39	4	594
GeneFamily	Fibronectin type III domain containing	CSF3R TIE1 ROBO3	4.92e-03	160	39	3	555
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	CEACAM5 ROBO3 ADAMTSL3	5.01e-03	161	39	3	593
CoexpressionAtlas	dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#4_top-relative-expression-ranked_1000	JCAD UBALD2 CHD7 GARRE1	5.85e-06	44	57	4	gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k4_1000
CoexpressionAtlas	PP_MEG_top-relative-expression-ranked_2500_k-means-cluster#5	CSF3R TIE1 HLA-DMA FUT4 FUT7 CMAHP C16orf54	5.20e-05	364	57	7	PP_MEG_2500_K5
ToppCell	Endothelial-B-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	JCAD LRCH2 TIE1 DACT2 ADAMTSL3	3.62e-06	167	62	5	6a03d16165e0b003092c39972928981abd4a75aa
ToppCell	Nasal_Brush-Epithelial-Ionocytes\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	CLCNKA CLCNKB LTBP2 LONRF2 NRP1	4.18e-06	172	62	5	04fabb40fa9357d8902f3b04adc15231626cd9f8
ToppCell	Nasal_Brush-Epithelial-Ionocytes\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	CLCNKA CLCNKB LTBP2 LONRF2 NRP1	4.18e-06	172	62	5	dd3a23dc78dc6939f41126f8d7bd23a2e4713647
ToppCell	COVID-19-Epithelial-Ionocytes\|Epithelial / Condition, Lineage and Cell class	INTS6L CLCNKA CLCNKB PKD2L1 LTBP2	5.36e-06	181	62	5	4a8d4f2709c1b25f908867f1b2fae1d2d0abf1d4
ToppCell	E17.5-Endothelial-capillary_endothelial_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	JCAD TIE1 ACE GARRE1 NRP1	6.28e-06	187	62	5	61b8a53f29bb8b33c69f680b8359a1143a23999d
ToppCell	P03-Endothelial-unknown_endothelial_cell-endothelial_unknown_1\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	JCAD TIE1 ACE GARRE1 NRP1	6.78e-06	190	62	5	347c7bf67ade235a4e2320db6a75ce0dab8744f9
ToppCell	E17.5-Endothelial\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	JCAD TIE1 ACE GARRE1 NRP1	6.78e-06	190	62	5	4fb76195ec9d6e0260a628eef6c2b3705acce787
ToppCell	P03-Endothelial-unknown_endothelial_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	JCAD TIE1 ACE GARRE1 NRP1	6.78e-06	190	62	5	0c7da05fbd3f095dde7550585209c056f0b76990
ToppCell	PSB-critical-LOC-Epithelial-Ionocyte\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CLCNKA CLCNKB PKD2L1 LTBP2 NRP1	6.96e-06	191	62	5	8f4637e801554e2343b974fe7794f01dd2151418
ToppCell	Endothelial-B\|World / shred on cell class and cell subclass (v4)	JCAD TIE1 ACE GARRE1 NRP1	6.96e-06	191	62	5	8b7857dee69d0ba3e59e230c9fd372e14695299e
ToppCell	facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JCAD TIE1 ACE GARRE1 NRP1	7.14e-06	192	62	5	4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c
ToppCell	Endothelial\|World / shred on cell class and cell subclass (v4)	JCAD TIE1 ACE GARRE1 NRP1	7.14e-06	192	62	5	2b13cca5c4b58628dbbbb356859632dba66d43f9
ToppCell	facs-Lung-18m-Endothelial-capillary_endothelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	JCAD TIE1 ACE GARRE1 NRP1	7.32e-06	193	62	5	ee4b31d9c92f8fd0d3ddb5e723b82300fcb459d1
ToppCell	PND10-Endothelial-Endothelial_blood-vessel\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	JCAD TIE1 ACE GARRE1 NRP1	7.32e-06	193	62	5	1d8acf81dcbfe81c7a73ce50c9f38fe0cbc74486
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	JCAD TIE1 ACE GARRE1 NRP1	7.32e-06	193	62	5	097a244cf37ce6c1ace9bae56beb7de59442cd6b
ToppCell	facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	JCAD TIE1 ACE GARRE1 NRP1	7.32e-06	193	62	5	7401e276b644b254c692160d0e7417ec28d50aa4
ToppCell	PND10-Endothelial\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	JCAD TIE1 ACE GARRE1 NRP1	7.32e-06	193	62	5	f3c743b340fc588bc8effd375b12e2c7cbfa49d2
ToppCell	PND14-Endothelial\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	JCAD TIE1 ACE GARRE1 NRP1	7.50e-06	194	62	5	cee89d4340738f09d07a159cd6aeee4300776988
ToppCell	PND14-Endothelial-Endothelial_blood-vessel\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	JCAD TIE1 ACE GARRE1 NRP1	7.50e-06	194	62	5	32962060d80f3edffbe9f0ecad3000c3a9817865
ToppCell	facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JCAD TIE1 ACE GARRE1 NRP1	7.50e-06	194	62	5	f159ef8541d75a4e98468947f231bb463bec922c
ToppCell	PND07-Endothelial-Endothelial_blood-vessel\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	JCAD TIE1 ACE GARRE1 NRP1	7.50e-06	194	62	5	12496bc964d1c572241410524a89ca1a9fdb7e34
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	JCAD TIE1 ACE GARRE1 NRP1	7.50e-06	194	62	5	46e36817fd1ed27af8013375214c38c9a9271640
ToppCell	PND07-Endothelial\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	JCAD TIE1 ACE GARRE1 NRP1	7.50e-06	194	62	5	d1080c86884916c22894b27994141463f5919812
ToppCell	facs-Lung-18m-Endothelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	JCAD TIE1 ACE GARRE1 NRP1	7.50e-06	194	62	5	3b5ba12375102598468cb09e66af9241b66c3cf9
ToppCell	droplet-Lung-LUNG-1m-Endothelial-Capillary_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JCAD TIE1 ACE GARRE1 NRP1	7.50e-06	194	62	5	f6c9cc362ccdbc7e790f7c8d1c56cab3557c5306
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	JCAD TIE1 ACE GARRE1 NRP1	7.50e-06	194	62	5	c6cee7d15af76f9a60d7f414ef0bcc1735c47b7a
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	JCAD TIE1 ACE GARRE1 NRP1	7.50e-06	194	62	5	44c7d4b75f3b7c9301eba20610e548a01a84ae40
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	JCAD TIE1 ACE GARRE1 NRP1	7.50e-06	194	62	5	7f24023df47935286f185dd428d48797daf26f49
ToppCell	PND03-Endothelial-Endothelial_blood-vessel\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	JCAD TIE1 ACE GARRE1 NRP1	7.50e-06	194	62	5	f93f5148b136819d87faef89707dbaba07d6c2b5
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	JCAD TIE1 ACE GARRE1 NRP1	7.69e-06	195	62	5	d700e959e060932e3854a9cf294799465efbe18b
ToppCell	PND03-Endothelial\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	JCAD TIE1 ACE GARRE1 NRP1	7.89e-06	196	62	5	a529681d822a95dd1980b7b1c71dc61aaf0baecd
ToppCell	3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	JCAD TIE1 ANXA2R ACE NRP1	8.08e-06	197	62	5	98e34e8612f111bb667a574de1faaa785d318ca4
ToppCell	Control_saline\|World / Treatment groups by lineage, cell group, cell type	JCAD TIE1 ACE GARRE1 NRP1	8.49e-06	199	62	5	11c9c1779caceb725ecccf3f23b7d4e6dbd1af64
ToppCell	LPS_IL1RA-Endothelial-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	JCAD TIE1 ACE GARRE1 NRP1	8.70e-06	200	62	5	72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TIE1 CHD7 ACE GARRE1 NRP1	8.70e-06	200	62	5	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	LPS_IL1RA-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	JCAD TIE1 ACE GARRE1 NRP1	8.70e-06	200	62	5	5c092b2ecc081b5d04476c56333c338cd89ab984
ToppCell	Control_saline-Endothelial-Endothelial-Alv_Gen_Intermediate\|Control_saline / Treatment groups by lineage, cell group, cell type	JCAD TIE1 ACE GARRE1 NRP1	8.70e-06	200	62	5	041a34080120c9f613373c20dcc366292f558040
ToppCell	Control_saline-Endothelial-Endothelial\|Control_saline / Treatment groups by lineage, cell group, cell type	JCAD TIE1 ACE GARRE1 NRP1	8.70e-06	200	62	5	e77eba6172cabf85b8028638ed35299f2f079cd8
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	JCAD TIE1 ACE GARRE1 NRP1	8.70e-06	200	62	5	b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a
ToppCell	Control_saline-Endothelial\|Control_saline / Treatment groups by lineage, cell group, cell type	JCAD TIE1 ACE GARRE1 NRP1	8.70e-06	200	62	5	3372c488a39fe812fa94e4f0564594186fea3db5
ToppCell	Control-Epithelial-Ionocyte\|Epithelial / Disease state, Lineage and Cell class	CLCNKA CLCNKB PKD2L1 LTBP2	6.47e-05	155	62	4	4b9369b203a4d7071c56d3d8e6b450e9a0121c41
ToppCell	droplet-Lung-nan-21m-Myeloid-Intermediate_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HLA-DMA APOBEC1 FUT4 ACE	7.32e-05	160	62	4	0b8151037b28f52a21918856a1e9336e8d5edb90
ToppCell	droplet-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l1-4\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CSF3R HLA-DMA APOBEC1 CHD7	7.32e-05	160	62	4	6329b0f02f9509086e563c2ed762a8ec693883b5
ToppCell	droplet-Lung-nan-21m-Myeloid-intermediate_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HLA-DMA APOBEC1 FUT4 ACE	7.32e-05	160	62	4	4738d0c73d8c3508e5b5beb6c61e0ad551d9b949
ToppCell	ILEUM-non-inflamed-(3)_pDC\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	FUT7 LONRF2 DNAH10OS LILRA4	7.86e-05	163	62	4	bc5411702badab39143905aa51676b4bbfad2041
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-B_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	B3GALT4 LINC01599 LILRA4 C16orf54	8.24e-05	165	62	4	7039bb5a7af4684fbd1192230864e5cd6936e83c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-B_Cell-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	B3GALT4 LINC01599 LILRA4 C16orf54	8.24e-05	165	62	4	d2c79653710b139794170f3d72f11392fc548ac7
ToppCell	TCGA-Colorectal\|World / Sample_Type by Project: Shred V9	CEACAM5 APOBEC1 FUT3 FUT4	8.44e-05	166	62	4	c018cd8c7a82251c67e3dc812d4d21e527a43456
ToppCell	ILEUM-non-inflamed-(3)_MNP-(3)_pDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	LRCH2 LONRF2 DNAH10OS LILRA4	8.64e-05	167	62	4	8ddf9da71a7c4ed53588435db826563a24cee616
ToppCell	NS-critical-d_16-33-Epithelial-Ionocyte\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CLCNKA CLCNKB LTBP2 RTKN	8.84e-05	168	62	4	6a233045638cb83dab64789b996b7598c325001e
ToppCell	severe-Myeloid-mDC\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CEACAM5 HLA-DMA SLC10A4 MRPL3	8.84e-05	168	62	4	eff37a92d41624924201372cc09f9eb07b60aec1
ToppCell	TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue\|TCGA-Colorectal / Sample_Type by Project: Shred V9	CLCNKB CMTM5 LONRF2 ADAMTSL3	9.04e-05	169	62	4	41cb92b0558f0d5a3e511058efd9110258b88ee3
ToppCell	TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue-Rectum_normal_tissue\|TCGA-Colorectal / Sample_Type by Project: Shred V9	CLCNKB CMTM5 LONRF2 ADAMTSL3	9.04e-05	169	62	4	91f4b6a14708e701b2af22989004282041777491
ToppCell	3'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ACSM5 FUT7 LONRF2 LILRA4	9.25e-05	170	62	4	db0ec8b7ecbb4db108fc35c564df4b740f65cc8f
ToppCell	3'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ACSM5 FUT7 LONRF2 LILRA4	9.25e-05	170	62	4	88f6804e973863245ca1c7e5e6656d4a8b824da9
ToppCell	3'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ACSM5 FUT7 LONRF2 LILRA4	9.25e-05	170	62	4	dad3aaf7d9f7bafdbddee51610f03f2359e587ae
ToppCell	COVID_vent-Lymphocytic-Dendritic-pDC\|COVID_vent / Disease condition, Lineage, Cell class and subclass	HLA-DMA RTKN LILRA4 NRP1	9.46e-05	171	62	4	779c951d274ecbd1d546ac425d6c8e718623be5a
ToppCell	COVID_vent-Lymphocytic-Dendritic\|COVID_vent / Disease condition, Lineage, Cell class and subclass	HLA-DMA RTKN LILRA4 NRP1	9.46e-05	171	62	4	debbb071d260639b16269c94d172766908325c58
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Neutrophil\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CSF3R SP5 FUT7 C16orf54	9.46e-05	171	62	4	ef9397cec7f5c217d34583f26270af7ed7fbcebf
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-pDC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HLA-DMA FUT7 LILRA4 C16orf54	9.68e-05	172	62	4	d40a8bd61114b49a5837c836136a13c37c8f7de0
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Ibsp-Inhibitory_Gad1Gad2_Htr3a.Ibsp_(Interneuron,__(candidate_CGE-derived_7))\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MEIOSIN FUT4 FUT7	9.78e-05	64	62	3	c13a7edad4d52a955e2c2247139246522d9e4463
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Ibsp-Inhibitory_Gad1Gad2_Htr3a.Ibsp_(Interneuron,__(candidate_CGE-derived_7))-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MEIOSIN FUT4 FUT7	9.78e-05	64	62	3	eefb4573ec4ff8efe602543ccbe555dbef1c4d54
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Ibsp\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MEIOSIN FUT4 FUT7	9.78e-05	64	62	3	fcc0f3fa0b462620d031aae810a01fadb7c01202
ToppCell	Bronchial_Brush-Epithelial-Ionocytes\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	CLCNKA CLCNKB PKD2L1 LTBP2	9.90e-05	173	62	4	e1de849dcd96063136bdac87e050ddbd55cabdcc
ToppCell	Bronchial_Brush-Epithelial-Ionocytes\|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	CLCNKA CLCNKB PKD2L1 LTBP2	9.90e-05	173	62	4	f2a8f4918c1fb68d98bc3f33cd624de0f0f11e06
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INTS6L B4GALT7 HLA-DMA FUT7	1.01e-04	174	62	4	ff13a5c55d18b951315908f33cb47c7f9cb901bf
ToppCell	facs-Mammary_Gland-Mammary_Gland-3m-Endothelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSF3R TIE1 CMTM5 C16orf54	1.03e-04	175	62	4	c36b4526970db9ccfbe2c70b00961fab9f13b133
ToppCell	facs-Mammary_Gland-Mammary_Gland-3m-Endothelial-endothelial_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSF3R TIE1 CMTM5 C16orf54	1.03e-04	175	62	4	c1e082538f31b5c98ac63f71dcca4a1211a14708
ToppCell	facs-Mammary_Gland-Mammary_Gland-3m-Endothelial-nan\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSF3R TIE1 CMTM5 C16orf54	1.03e-04	175	62	4	2f9b5bdf8a62e8e99d1c4f677a8e5525bfd3b4ce
ToppCell	mild-Myeloid-pDC\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	TIE1 RTKN LILRA4 NRP1	1.06e-04	176	62	4	59a9c262c252b7d220a025837922d98e9d6b0a24
ToppCell	3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-cDC1\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CEP85 HLA-DMA SPAG8 FUT7	1.06e-04	176	62	4	87f90834c7278516beff7814b78f7c75732d9bf0
ToppCell	facs-Aorta\|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JCAD TIE1 LTBP2 NRP1	1.06e-04	176	62	4	0b3491451be02c18a16cdb875645be47eb867a7f
ToppCell	3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CLCNKA CLCNKB APOBEC1 LTBP2	1.08e-04	177	62	4	6d89042bda8e244babb68929e84b25edcb545a77
ToppCell	3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CLCNKA CLCNKB APOBEC1 LTBP2	1.08e-04	177	62	4	daaccf1249dcf816df4caca695a944f53078291a
ToppCell	3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CLCNKA CLCNKB APOBEC1 LTBP2	1.08e-04	177	62	4	338bdda26796bf4e16072878c070212d1006cf57
ToppCell	tumor_Lung-Endothelial_cells-EPCs\|tumor_Lung / Location, Cell class and cell subclass	JCAD TIE1 ACE GARRE1	1.08e-04	177	62	4	f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5
ToppCell	3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CLCNKA CLCNKB APOBEC1 LTBP2	1.08e-04	177	62	4	c5a16f984c836dbf7d0faf061677844167ab612a
ToppCell	NS-critical-LOC-Epithelial-Ionocyte\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CLCNKA CLCNKB LTBP2 RTKN	1.13e-04	179	62	4	65a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c
ToppCell	metastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs\|metastatic_Brain / Location, Cell class and cell subclass	ADRB3 HLA-DMA FUT7 LILRA4	1.15e-04	180	62	4	51727cb66fe7a7709453f7026e0ff3d6c93d5aa5
ToppCell	droplet-Liver-Npc-21m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JCAD TIE1 GARRE1 NRP1	1.20e-04	182	62	4	dc55de945c6f78f32eb3a1b3520835eb8417e068
ToppCell	tumor_Lung-Myeloid_cells-CD207+CD1a+_LCs\|tumor_Lung / Location, Cell class and cell subclass	DCANP1 ADRB3 HLA-DMA LILRA4	1.20e-04	182	62	4	243779ba1009097f8fafa1a691e296ec3aeefc04
ToppCell	10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	JCAD LRCH2 TIE1 NRP1	1.20e-04	182	62	4	997d37ca2af661c92a56add888762724dfccc890
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	JCAD TIE1 ACE NRP1	1.20e-04	182	62	4	a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50
ToppCell	E18.5-samps-Endothelial-Mature_fetal_endothelial\|E18.5-samps / Age Group, Lineage, Cell class and subclass	JCAD TIE1 ACE GARRE1	1.20e-04	182	62	4	7af3b2029b7f55b923d5a4b764d4292f4ea48599
ToppCell	E16.5-samps-Endothelial-Immature_fetal_endothelial-Intermediate_Endothelial\|E16.5-samps / Age Group, Lineage, Cell class and subclass	JCAD TIE1 ACE GARRE1	1.20e-04	182	62	4	fec1caf867b1dc87b24504d895ee1a27df78062e
ToppCell	E18.5-samps-Endothelial\|E18.5-samps / Age Group, Lineage, Cell class and subclass	JCAD TIE1 ACE GARRE1	1.20e-04	182	62	4	e2d799e6e7526176a6fe6515b8fbe4d83d3a3ea1
ToppCell	droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JCAD TIE1 GARRE1 NRP1	1.20e-04	182	62	4	010a7364da46101cb5068891fd7bc712ea8f13bd
ToppCell	droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JCAD TIE1 GARRE1 NRP1	1.20e-04	182	62	4	b1ec2015aad1181eac1bbf8d48ad6f2f7ed24a01
ToppCell	Control-Endothelial-Endothelial-Activated_Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	JCAD TIE1 ACE NRP1	1.23e-04	183	62	4	e81c142770f44fd902b0631bc360c5b5339d4c75
ToppCell	PND14\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	INTS6L HLA-DMA ACE NRP1	1.25e-04	184	62	4	1bfee4eb121e76a79f48b06b45f05d124fbbedba
ToppCell	(4)_Endothelial_cells-(40)_EC-arterial\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	TIE1 ACE NRP1 C16orf54	1.25e-04	184	62	4	7e1a2971321ddcfa00d78d3e3ba7960e532f9392
ToppCell	URO-Myeloid-pDC\|URO / Disease, Lineage and Cell Type	HLA-DMA FUT7 LILRA4 NRP1	1.25e-04	184	62	4	0edb5dd003c2bca0b9e3ec18d03610d68bd52538
ToppCell	367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	MAP3K10 CHD7 GARRE1	1.28e-04	70	62	3	37e34ef782b253c43628d5bb2fe5e0294573d0ef
ToppCell	Control-Endothelial-Endothelial-Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	JCAD TIE1 ACE NRP1	1.34e-04	187	62	4	ea9d34bcd3bd1f36745846309ede349773de501a
ToppCell	E17.5-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	JCAD TIE1 ACE GARRE1	1.34e-04	187	62	4	e9aa0a5a0f8e2593de63e83b56b53ae33e60af49
ToppCell	E17.5-Endothelial-unknown_endothelial_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	JCAD TIE1 ACE NRP1	1.34e-04	187	62	4	da885c26ccc5189b1ff1f607552e00a5c0e49e7e
ToppCell	E12.5-Epithelial-epithelial_progenitor_cell\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SLC10A4 DACT2 SP5 CHD7	1.34e-04	187	62	4	ab6f4d387218b4651fdadbf269806c1ddc96a1d2
ToppCell	facs-Aorta-Heart-3m-Endothelial-nan\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JCAD TIE1 GARRE1 NRP1	1.34e-04	187	62	4	df0279b7e94e26f5541b0e2a0ce56befa96ec8ca
ToppCell	E17.5-Endothelial-unknown_endothelial_cell-endothelial_unknown_1\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	JCAD TIE1 ACE NRP1	1.34e-04	187	62	4	1f358d02ec69d44dea2e2831af9473ed05dcf8cc
ToppCell	Monocytes-M2-like_CD16+_macrophages\|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis	JCAD ACSM5 LTBP2 NRP1	1.34e-04	187	62	4	59e31c51183ed4c9a3d0792c8005ea3a12b28dfa
Drug	AC1MPID6	FUT3 FUT4 FUT7	3.82e-07	6	62	3	CID003411618
Drug	AC1MQWF5	FUT3 FUT4 FUT7	2.28e-06	10	62	3	CID003458642
Drug	3'SLN	FUT3 FUT4 FUT7	8.55e-06	15	62	3	CID000643986
Drug	Grape Seed Proanthocyanidins	VN1R3 TUBGCP6 PGGHG CLCNKB ANXA2R NAGLU PKD2L1 ZNF74 C22orf39 TNRC6C FUT3	1.68e-05	852	62	11	ctd:C511402
Drug	Benzydamine hydrochloride [132-69-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A	PGGHG ROBO3 SPAG8 MYO15A FUT7 LILRA4	1.69e-05	199	62	6	3169_UP
Drug	AC1MPID3	FUT3 FUT4 FUT7	1.81e-05	19	62	3	CID003411617
Drug	(2S,3R,4S,5S,6R)-2-benzyl-6-(hydroxymethyl)oxane-3,4,5-triol	FUT3 FUT4 FUT7	3.28e-05	23	62	3	CID010332525
Drug	Catechin	VN1R3 TUBGCP6 PGGHG CLCNKB ANXA2R NAGLU PKD2L1 ZNF74 C22orf39 TNRC6C FUT3	3.68e-05	928	62	11	ctd:D002392
Drug	f119	HLA-DMA ACE	4.36e-05	4	62	2	CID000009602
Drug	AC1L1B78	MAN2B2 PKD2L1 MYO15A ACE	4.46e-05	72	62	4	CID000001313
Drug	sLex	CEACAM5 FUT3 FUT4 FUT7	4.46e-05	72	62	4	CID004564901
Drug	H S Q	B4GALT7 CEACAM5 MAN2B2 CLCNKA NAGLU SH2D3A FUT3	4.63e-05	351	62	7	CID000000897
Drug	rhamnose	CEACAM5 MAN2B2 NAGLU FUT3 FUT4 FUT7 ACE	5.06e-05	356	62	7	CID000000840
Drug	sLea	CEACAM5 FUT3 FUT4 FUT7	6.11e-05	78	62	4	CID000643993
Drug	2-Methyl-4-chlorophenoxyacetic Acid	CLCNKA CLCNKB	7.26e-05	5	62	2	ctd:D008456
Drug	2'-fucosyllactose	FUT3 FUT4 FUT7	7.41e-05	30	62	3	CID000170484
Drug	p904	B4GALT7 MAN2B2 NAGLU FUT3 FUT4 FUT7	8.72e-05	267	62	6	CID000065150
Drug	lacto-N-tetraose	FUT3 FUT4 FUT7	9.01e-05	32	62	3	CID000440993
Drug	valeric anhydride	HLA-DMA ACE	1.09e-04	6	62	2	CID000074959
Disease	Bartter disease type 4B	CLCNKA CLCNKB	3.93e-06	2	59	2	cv:C4310805
Disease	BARTTER SYNDROME, TYPE 4B	CLCNKA CLCNKB	3.93e-06	2	59	2	C2751312
Disease	BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	CLCNKA CLCNKB	3.93e-06	2	59	2	C4310805
Disease	Bartter disease type 3 (implicated_via_orthology)	CLCNKA CLCNKB	3.93e-06	2	59	2	DOID:0110144 (implicated_via_orthology)
Disease	Bartter disease type 4b (is_implicated_in)	CLCNKA CLCNKB	3.93e-06	2	59	2	DOID:0110146 (is_implicated_in)
Disease	BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	CLCNKA CLCNKB	3.93e-06	2	59	2	613090
Disease	Bartter disease (implicated_via_orthology)	CLCNKA CLCNKB	3.93e-06	2	59	2	DOID:445 (implicated_via_orthology)
Disease	Bartter syndrome	CLCNKA CLCNKB	5.87e-05	6	59	2	cv:C0004775
Disease	candidiasis (implicated_via_orthology)	FUT3 FUT4 FUT7	9.49e-05	44	59	3	DOID:1508 (implicated_via_orthology)
Disease	nephrogenic diabetes insipidus (implicated_via_orthology)	CLCNKA CLCNKB	1.75e-04	10	59	2	DOID:12387 (implicated_via_orthology)
Disease	serum carcinoembryonic antigen measurement	CEACAM5 FUT3	7.30e-04	20	59	2	EFO_0005760
Disease	bipolar disorder, schizophrenia, response to lithium ion	HLA-DMA CMAHP	7.30e-04	20	59	2	GO_0010226, MONDO_0004985, MONDO_0005090
Disease	Left Ventricular Hypertrophy	ADRB3 ACE	1.14e-03	25	59	2	C0149721
Disease	hypertension (is_implicated_in)	ADRB3 CLCNKB ACE	1.85e-03	121	59	3	DOID:10763 (is_implicated_in)
Disease	sensorineural hearing loss (is_implicated_in)	CLCNKA MYO15A	1.99e-03	33	59	2	DOID:10003 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
VWAPRQSPPPDWHLP	C22orf39	121	Q6P5X5
SDPWHPPSLSPNSWN	DCANP1	181	Q8TF63
PGDEAHWPQYPPLWM	APOBEC1	161	P41238
LGWPEYQWHPPLPDN	ACE	621	P12821
ESEWAPWQPQLPCEP	DNAH10OS	101	P0CZ25
MESPSAPPHRWCIPW	CEACAM5	1	P06731
VSEEQWPHTWGPFPP	B3GALT4	246	O96024
RVEGPPAWEAAPWPS	C16orf54	11	Q6UWD8
LEEAGHRPPNPAFWW	ACSM5	66	Q6NUN0
MAPWPHENSSLAPWP	ADRB3	1	P13945
LPWSSPLHPWDRQQD	ANXA2R	121	Q3ZCQ2
VWIPEPFHAEVPADW	CHD7	1771	Q9P2D1
NLHTWDGPLPPSWHI	NAGLU	206	P54802
HQVAEPPEDWPALIW	EDC4	941	Q6P2E9
HWPIPESFWPDQNLP	INTS6L	286	Q5JSJ4
PPEFWVSAHPGWLQV	KIRREL3-AS3	61	Q8N7Y1
PRPWAPHALPFWDTP	SLC10A4	86	Q96EP9
LWAEPGPVITWHNPV	LILRA4	31	P59901
PWEPTPSAPPARWGH	MAP3K10	651	Q02779
APAHVPPAPQASWWA	MYO15A	706	Q9UKN7
PPAPQASWWAFVEPP	MYO15A	711	Q9UKN7
PPWHRWGTLPQAAAP	MYO15A	1076	Q9UKN7
PPDWPPPWGIQAHTA	FUT4	246	P22083
WSEELQPGHPRAWPP	JCAD	916	Q9P266
PPEPPPEHWEEDASW	B4GALT7	76	Q9UBV7
VWHWPFTDQPPELPS	FUT7	51	Q11130
APTQPWWPNTPGDSV	TUBGCP6	1351	Q96RT7
EPEPQSNPSGPAWSW	LONRF2	686	Q1L5Z9
GLPPAHDPWEPKPDW	SLC9A3R2	111	Q15599
AGPWAPHLEAELWPS	PGGHG	651	Q32M88
WLPAWTPENSPQGSP	MEIOSIN	326	C9JSJ3
WALPPAPHSYINEWL	NRP1	471	O14786
NTWAPAPDTWAPAPD	ILRUN	241	Q9H6K1
AAPQPSLEWDPAHWP	DACT2	526	Q5SW24
PHAWWVPPTAPGTSL	LINC01599	266	Q8WXQ3
NWPPMDDAHRTWPFP	GARRE1	876	O15063
PLPSQVWQPSPDTWH	CEP85	261	Q6P2H3
LPHSWAVPEAPTPMW	HLA-DMA	21	P28067
DPHSLWVGWEPPNPW	CSF3R	441	Q99062
PPPWLPASPGHSLWD	LTBP2	511	Q14767
WPAPRGHLDPTWALQ	MAN2B2	391	Q9Y2E5
VEPSWPWHPGLEQAA	LINC02913	131	Q8NAJ2
DEQPWPESHPIIWQS	LRCH2	536	Q5VUJ6
KDEPWPIHPWEPGSF	MRPL3	81	P09001
WLEPWSGQPAHPPLN	FUT3	171	P21217
VAPAPDWTHPLPWGR	RTKN	501	Q9BST9
PWEPPAAWELQEAPA	RTL3	96	Q8N8U3
SSINWPPEFHPGVPW	TNRC6C	1381	Q9HCJ0
WSQHCPWEPQKQPPW	SPAG8	231	Q99932
AVWSGHSPPPPQENW	REPS1	216	Q96D71
NPAPDDLPWWSIPQA	SP5	181	Q6BEB4
PGVVTSPELPEHWWQ	SPATA31E1	616	Q6ZUB1
PPLVRGPWHNTNSPW	DIP2C-AS1	91	Q8N8Z3
PAFARGWWLLHEPPS	CMAHP	61	Q9Y471
PGWHTPAAVPWVPAP	CMTM5	126	Q96DZ9
PPWPEELDPQHLWWE	CLCNKA	376	P51800
PPWPEELDPQHLWWE	CLCNKB	376	P51801
NHWPADTSLQPIHPW	WFDC5	176	Q8TCV5
APPTPAPDHWWMEAP	nan	76	Q8N377
PSQSCPEPEAPWWEA	SH2D3A	246	Q9BRG2
DCPEPLLQPWLEGWH	TIE1	541	P35590
PAPYSWLADSWPHPS	ROBO3	956	Q96MS0
WKHPQPAPAVTPDPW	PKD2L1	756	Q9P0L9
PFWASSPPSHQAPWI	UBALD2	111	Q8IYN6
AAPWAPAPAMVWDVP	ZNF74	161	Q16587
PPSLHMSLFPNPSWW	VN1R3	251	Q9BXE9
PPPQEPFWEPGNWSH	ADAMTSL3	1421	P82987